Insider · CIK 0001778307

Cheng Andrew

Reports to the SEC for 5 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001778307

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-12	DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+30.4K sh	—	—	30,350
2026-05-21	VERAVera Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+17.1K sh	—	—	17,084
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−292K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−2,328 sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−4,739 sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−234K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−3,421 sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−165K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−375K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−239K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−87.2K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−3,527 sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−160K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−23.8K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−5,032 sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−10K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−233K sh	—	—	0
2025-12-09	Akero Therapeutics, Inc.D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−277K sh	—	—	0
2025-11-20	Akero Therapeutics, Inc.G Gift	Director, President and CEO	GGift	−74.5K sh	—	—	436,837
2025-11-12	Akero Therapeutics, Inc.G Gift	Director, President and CEO	GGift	−14.7K sh	—	—	511,375
2025-10-10	Akero Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+30K sh	$19.87	+$596K	556,114
2025-10-10	Akero Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−30K sh	$53.98	−$1.62M	526,114
2025-10-10	Akero Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−30K sh	—	—	380,017
2025-10-08	Akero Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−52.2K sh	—	—	0
2025-10-08	Akero Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+52.2K sh	$0.61	+$32.1K	526,114
2025-09-11	Akero Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−1,796 sh	$43.02	−$77.3K	473,902
2025-09-10	Akero Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−13K sh	—	—	0
2025-09-10	Akero Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−22.5K sh	$42.99	−$968K	483,173
2025-09-10	Akero Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+1,919 sh	$19.87	+$38.1K	505,698
2025-09-10	Akero Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−7,317 sh	$43.99	−$322K	475,856
2025-09-10	Akero Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−158 sh	$44.62	−$7,049.96	475,698
2025-09-10	Akero Therapeutics, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+13K sh	$6.36	+$82.9K	503,779
2025-09-10	Akero Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−1,919 sh	—	—	410,017
2025-08-11	Akero Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−400 sh	$49.44	−$19.8K	490,757
2025-08-11	Akero Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−10.8K sh	$48.07	−$519K	509,962
2025-08-11	Akero Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−18.8K sh	$48.87	−$919K	491,157
2025-07-10	Akero Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−15.3K sh	$51.73	−$792K	520,757
2025-07-10	Akero Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−14.7K sh	$50.57	−$743K	536,071
2025-06-30	Akero Therapeutics, Inc.A Award	Director, President and CEO	AAward	+890 sh	$23.87	+$21.2K	550,757
2025-06-18	Akero Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−6,620 sh	$54.84	−$363K	549,867
2025-06-10	Akero Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−15.2K sh	$54.35	−$824K	564,324
2025-06-10	Akero Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−7,837 sh	$53.99	−$423K	556,487
2025-06-10	Akero Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−14.8K sh	$53.76	−$798K	579,482
2025-05-14	VERAVera Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+14K sh	—	—	14,000
2025-05-12	Akero Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−7,200 sh	$41.00	−$295K	617,124
2025-05-12	Akero Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−22.8K sh	$41.63	−$949K	594,324
2025-04-10	Akero Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−30K sh	$35.23	−$1.06M	624,324
2025-03-12	Akero Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−1,738 sh	$44.88	−$78K	654,324
2025-03-10	Akero Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−1,216 sh	$42.31	−$51.5K	656,062
2025-03-10	Akero Therapeutics, Inc.S Sale	Director, President and CEO	SSale	−28.8K sh	$41.75	−$1.2M	657,278

Recent filings

Accepted (ET)
Aug 134
Cheng Andrew0001193125-26-349537
SEC(opens sec.gov)
May 264
Cheng Andrew0001778307-26-000002
SEC(opens sec.gov)
Dec 94
Cheng Andrew0001193125-25-312131
SEC(opens sec.gov)
Nov 214
Cheng Andrew0001193125-25-291688
SEC(opens sec.gov)
Nov 134
Cheng Andrew0001193125-25-280748
SEC(opens sec.gov)

Companies

Address

C/O DAMORA THERAPEUTICS, INC. 221 CRESCENT ST., BLDG 23, STE 105

WALTHAM, MA, 02453